Isonics Corporation Announces New V.P. for Commercialization in Homeland Security Division

Isonics Corporation, a manufacturer involved in the development of next-generation technology for the homeland security and semiconductor markets, has announced that Dr. Daniel J. Grady, longtime vice president of the Isonics Life Sciences division, has been named to the post of Vice President, Product Development and Commercialization for the Company's homeland security division.

The announcement was made by James E. Alexander, Isonics' chairman and CEO. Grady, who holds a Ph.D. in nuclear engineering from the University of Michigan, will oversee product development, engineering and regulatory compliance for Isonics' NeutroTest explosive detection device, and for other products expected to be developed through Isonics' neutron-based trace detection technology.

"Dr. Grady's blend of technical and marketing experience at major technology companies such as TRW and GE provide a depth of experience highly relevant to the goals in our homeland security division," said Mr. Alexander. "Dan has a deep background in the successful development of high-technology products in both the medical systems and nuclear power industries, and we're fortunate we can apply his knowledge and leadership in our homeland security division."

Dr. Grady joined Isonics in 1995. He was previously Vice President of Research and Development at Sopha Medical Systems, a medical diagnostic imaging equipment manufacturer. He has served as Marketing Manager at GE Nuclear Energy, and worked for GE Nuclear Medicine in England and the United States. He has also held the post of Engineering Analysis Section Head for TRW.

In related news, Isonics is seeking a new director of commercialization, a position that was to be filled by Charles Minter. Shortly after commencement of his engagement, Mr. Minter informed the Company that he had elected to accept the newly-offered position of interim CEO for his previous consulting client, a medical device company, and thus would terminate his arrangement with Isonics. The new director of commercialization will report to Dr. Grady.

Lindsay Gardner, Isonics' Vice President of Corporate Development, will temporarily assume responsibility for the Life Sciences division, working with Dr. Grady to assure a smooth transition for customers and suppliers.